Showing results (211-220 of 310) with videos related to

Sort By:
Pageof 31
Endocrine|October 4, 2018
Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasmsKosmas Daskalakis, Eleftherios Chatzelis, Marina Tsoli, et al.
Journal of Clinical Medicine|August 26, 2023
Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective StudyAthanasios D Anastasilakis, Stergios A Polyzos, Panagiotis A Vorkas, et al.
Cancers|May 30, 2019
Malignant Pheochromocytomas/Paragangliomas and Ectopic Hormonal Secretion: A Case Series and Review of the LiteratureAnna Angelousi, Melpomeni Peppa, Alexandra Chrisoulidou, et al.
Hormones (Athens, Greece)|May 27, 2006
Laparoscopic surgery for adrenal tumors. A retrospective analysisGeorge N Zografos, Athina Markou, Chrisanthi Ageli, et al.
Cancers|May 5, 2021
Cardiovascular Toxicities Secondary to Biotherapy and Molecular Targeted Therapies in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsCharalampos Aktypis, Maria-Eleni Spei, Maria Yavropoulou, et al.
Endocrine Connections|April 27, 2019
Anti-tumour activity of everolimus and sunitinib in neuroendocrine neoplasmsKosmas Daskalakis, Marina Tsoli, Anna Angelousi, et al.
Endocrine|September 9, 2017
Altered expression of circadian clock genes in polyglandular autoimmune syndrome type IIIAnna Angelousi, Narjes Nasiri-Ansari, Eliana Spilioti, et al.
Clinical Endocrinology|September 14, 2012
The prevalence and relevance of adrenal masses in patients with sporadic gastroenteropancreatic neuroendocrine tumours (GEP-NET)George Kanakis, Kimberly Kamp, Konstantinos Tsiveriotis, et al.
Bone|December 25, 2025
Repurposing osteoporosis medications for other diseases: a narrative review by the European Calcified Tissue Society (ECTS)Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
Hemasphere|January 25, 2020
Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective StudyKonstantinos Anargyrou, Despina Fotiou, Theodoros P Vassilakopoulos, et al.
Pageof 31